Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.

FOLLOW US ON:

Recent Posts

Get in touch!

Fusce varius, dolor tempor interdum tristiquei bibendum service life.

147/I, Green Road, Gulshan Avenue, Panthapath, Dhaka

Canada’s innovation policy: designed in Ottawa, owned in America

Canadian research funding is failing to achieve our social, health and economic goals. Universities and colleges continue to produce world-class research, but that research too often yields no new product or service or is commercialized by foreign firms that sell it back to us at a

Read More

Ottawa Aims To Attract Top Research Talent

The federal government’s new plan will create research chairs at Canadian universities spread across eight areas of focus.

Read More

Working From Home Is Harming Young Employees. They’re Starting to See That.

Remote work means less training and opportunity for advancement, especially for younger workers, research suggests. Some are getting the message.

Read More
Eli Lilly Logo

Eli Lilly Reaches $1 Trillion in Value, Buoyed by Demand for Its Weight Loss Drugs

The booming market for weight-loss drugs has propelled Eli Lilly to become the first pharmaceutical company to hit $1 trillion, joining a select club of mostly tech companies that have surpassed that threshold.

Read More

$500M Cambridge Biotech Research Hub Abruptly Closes

Arena BioWorks was supposed to be a breath of fresh air for the Greater Boston life sciences market, but its bright bulb just went out.

Read More

Overcoming Canada’s innovation barrier will lead to more productivity

The latest federal budget includes $1.7-billion for attracting international talent, a welcome investment in a country where we struggle to turn scientific discoveries into innovations that drive economic growth.

Read More

Universities could jump to hire foreign researchers if Ottawa allocates funds

Universities have been waiting to see what direction the federal government will take as other countries have jumped on the potential hiring opportunity created by recent instability in U.S. academic funding.

Read More

Vimy Pharma: Company says product won’t be available in January, still aiming for 2026

As the race among drug makers heats up to deliver a generic form of the blockbuster drug Ozempic next year, Vimy Pharmaceuticals Inc., a new entrant to the field, is aiming to produce a made-inCanada version.

Read More

With measles elimination status in peril, country faces a wake-up call

Canadian health experts equipped with binders of information on the prolonged measles outbreak will travel in November to Mexico City, where an international committee will determine whether Canada maintains its elimination status for the disease.

Read More